Sofinnova Investments’s Jade Biosciences JBIO Stock Holding History

Sofinnova Investments’s Portfolio JBIO Stock Details JBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.39M	Hold	107,391	–	–	0.12%	45
2026 Q1	$1.51M	Hold	107,391	–	–	0.06%	67
2025 Q4	$1.66M	Hold	107,391	–	–	0.07%	57
2025 Q3	$927K	Hold	107,391	–	–	0.05%	57
2025 Q2	$1.07M	Hold	107,391	–	–	0.07%	55
2025 Q1	$9.43M	Hold	107,391	–	–	0.62%	39
2024 Q4	$9.96M	Hold	107,391	–	–	0.73%	33
2024 Q3	$7.86M	Hold	107,391	–	–	0.62%	34
2024 Q2	$6.24M	Hold	107,391	–	–	0.32%	54
2024 Q1	$111M	Hold	107,391	–	–	6.19%	4
2023 Q4	$85.1M	Hold	107,391	–	–	4.76%	6
2023 Q3	$51M	Hold	107,391	–	–	3.22%	8
2023 Q2	$64.5M	Hold	107,391	–	–	4.22%	6
2023 Q1	$75.8M	Hold	107,391	–	–	4.85%	6
2022 Q4	$110M	Hold	107,391	–	–	6.54%	3
2022 Q3	$62.3M	Hold	107,391	–	–	3.63%	5
2022 Q2	$58.7M	Hold	107,391	–	–	4.89%	4
2022 Q1	$68.9M	Hold	107,391	–	–	5.23%	5
2021 Q4	$44.3M	Hold	107,391	–	–	2.59%	7
2021 Q3	$78.9M	Hold	107,391	–	–	4.67%	4
2021 Q2	$85.8M	Buy	+107,391	New	+$85.8M	4.95%	3

Other funds holding JBIO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jupiter Topco New York $245B AUM

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sofinnova Investments's JBIO Position: Q2 2026 in Review

Sofinnova Investments held its Jade Biosciences (JBIO) position steady in Q2 2026 at 107,391 shares worth $2.39M. The position accounts for 0.12% of the portfolio, ranked #45.

Sofinnova Investments first reported a position in JBIO in Q2 2021 and has held it in 21 quarters since. The position peaked at $111M in Q1 2024. 154 funds tracked by Wall St. Rank hold JBIO as of Q2 2026.

Sofinnova Investments held 107,391 shares of Jade Biosciences worth $2.39M as of Q2 2026.
Sofinnova Investments left its Jade Biosciences share count unchanged in Q2 2026.
Jade Biosciences made up 0.12% of Sofinnova Investments's portfolio in Q2 2026, its #45 holding.
Sofinnova Investments first reported a position in Jade Biosciences in Q2 2021 and has held it in 21 quarters since.
Sofinnova Investments's Jade Biosciences position peaked at $111M in Q1 2024.
154 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2026.

Based on Sofinnova Investments's 13F filing for Q2 2026, filed 14 Aug 2026.